(Q35873676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Pharmacogenomics and stomach cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Giuseppe Toffoli

1 reference

10 August 2017

Erika Cecchin

series ordinal

1 reference

10 August 2017

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

627-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

New drugs for treatment of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Clinical pharmacology of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

High prevalence of the IVS14 + 1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms in the ABC drug transporter gene MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genetic polymorphisms in xenobiotic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Glutathione transferase P1 polymorphism in neuroblastoma studied by endonuclease restriction mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms of human liver carboxylesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

21 January 2018

Cancer pharmacogenetics

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Angiogenesis as a target for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

Biologists take tentative steps towards bespoke cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.627

21 January 2018

Identifiers

DOI

10.1517/14622416.5.6.627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15335285%20AND%20SRC:MED&resulttype=core&format=json